Journal of Antimicrobial Chemotherapy (1999) 43, 459-465
© 1999 The British Society for Antimicrobial Chemotherapy
Review |
A review of the role of antibiotic policies in the control of antibiotic resistance
Department of Medical Microbiology, Royal Infirmary, Aberdeen AB25 2ZN, UK
The optimal antibiotic control measures remain to be described and probably vary between institutions. Nevertheless, various control measures have been shown to be useful in reducing costs of therapy and total amounts of prescribing, while maintaining quality of care. More recently, interest has turned to whether antibiotic policies can reduce the spread of resistance and even reverse current high levels. Early studies indicated this was feasible, but mathematical models and the recent discovery of the role of transposons and integrons in multi-drug resistance have both cast doubt on likely future success in this area. Nevertheless, there have been some major successes in recent studies, both in the community and hospital. While cross-infection is a major impediment to control of resistance, there is little doubt that careful antibiotic prescribing can curtail the emergence and reduce the prevalence of resistance.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Mertz, M. Koller, P. Haller, M. L. Lampert, H. Plagge, B. Hug, G. Koch, M. Battegay, U. Fluckiger, and S. Bassetti Outcomes of early switching from intravenous to oral antibiotics on medical wards J. Antimicrob. Chemother., July 1, 2009; 64(1): 188 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Rezzonico, V. O. Stockwell, and B. Duffy Plant Agricultural Streptomycin Formulations Do Not Carry Antibiotic Resistance Genes Antimicrob. Agents Chemother., July 1, 2009; 53(7): 3173 - 3177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C K Ng, T C Wu, W M J Chan, Y S W Leung, C K P Li, D N C Tsang, and G M Leung Clinical and economic impact of an antibiotics stewardship programme in a regional hospital in Hong Kong Qual. Saf. Health Care, October 1, 2008; 17(5): 387 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Gould Antibiotic policies to control hospital-acquired infection J. Antimicrob. Chemother., April 1, 2008; 61(4): 763 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Landersdorfer, C. M. J. Kirkpatrick, M. Kinzig-Schippers, J. B. Bulitta, U. Holzgrabe, G. L. Drusano, and F. Sorgel Population Pharmacokinetics at Two Dose Levels and Pharmacodynamic Profiling of Flucloxacillin Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3290 - 3297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Nathwani and on behalf of Scottish Medicines Consortium (SMC) S Antimicrobial prescribing policy and practice in Scotland: recommendations for good antimicrobial practice in acute hospitals J. Antimicrob. Chemother., June 1, 2006; 57(6): 1189 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. E. Drummond Resistance is futile--a conference to promote the rational use of antimicrobials in acute hospitals J. Antimicrob. Chemother., February 1, 2006; 57(2): 171 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Isaacs Unnatural selection: reducing antibiotic resistance in neonatal units Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2006; 91(1): F72 - F74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M M van der Eerden, F Vlaspolder, C S de Graaff, T Groot, W Bronsveld, H M Jansen, and W G Boersma Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study Thorax, August 1, 2005; 60(8): 672 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Mayon-White and P. Wiffen Audit of antibiotic policies in the South East of England, 2004 J. Antimicrob. Chemother., July 1, 2005; 56(1): 204 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. M. Mol, J. E. Wieringa, P. V. NannanPanday, R. O. B. Gans, J. E. Degener, M. Laseur, and F. M. Haaijer-Ruskamp Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis J. Antimicrob. Chemother., April 1, 2005; 55(4): 550 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. A. Weller and C. E. Jamieson The expanding role of the antibiotic pharmacist J. Antimicrob. Chemother., August 1, 2004; 54(2): 295 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. El-Zimaity, A. M. Kearns, S. J. Dawson, S. Price, and G. A. J. Harrison Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area J. Antimicrob. Chemother., August 1, 2004; 54(2): 441 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Senn, B. Burnand, P. Francioli, and G. Zanetti Improving appropriateness of antibiotic therapy: randomized trial of an intervention to foster reassessment of prescription after 3 days J. Antimicrob. Chemother., June 1, 2004; 53(6): 1062 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Cook, P. G. Catrou, J. D. Christie, P. D. Young, and R. E. Polk Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram J. Antimicrob. Chemother., May 1, 2004; 53(5): 853 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Woodford, K. A. Wilson, and J. F. Marriott Documentation of antibiotic prescribing controls in UK NHS hospitals J. Antimicrob. Chemother., April 1, 2004; 53(4): 650 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Harris and J. C. Hartley Development of broad-range 16S rDNA PCR for use in the routine diagnostic clinical microbiology service J. Med. Microbiol., August 1, 2003; 52(8): 685 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Toltzis, M. J. Dul, C. Hoyen, A. Salvator, M. Walsh, L. Zetts, and H. Toltzis The Effect of Antibiotic Rotation on Colonization With Antibiotic-Resistant Bacilli in a Neonatal Intensive Care Unit Pediatrics, October 1, 2002; 110(4): 707 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tan, N. H. Nielsen, D. C. Young, Z. Trizna, and for the Council on Scientific Affairs, American Me Use of Antimicrobial Agents in Consumer Products Arch Dermatol, August 1, 2002; 138(8): 1082 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Dancer The problem with cephalosporins J. Antimicrob. Chemother., October 1, 2001; 48(4): 463 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. S. Lee, K. Y. Yuen, and C. R. Kumana {beta}-Lactam Antibiotic and {beta}-Lactamase Inhibitor Combinations JAMA, January 24, 2001; 285(4): 386 - 388. [Full Text] [PDF]
|
|
|
|
|
|
I. M. Gould Towards a common susceptibility testing method? J. Antimicrob. Chemother., June 1, 2000; 45(6): 757 - 762. [Full Text] [PDF]
|
|